T1	Participants 62 111	patients undergoing surgery for colorectal cancer
T2	Participants 265 314	patients undergoing surgery for colorectal cancer
T3	Participants 402 483	Patients were randomly allocated to control (n = 13) or treatment groups (n = 12)
